论文部分内容阅读
目的研究胺碘酮治疗充血性心力衰竭伴室性心律失常90例的疗效观察。方法所有患者在最近3周内未接受抗心律失常药物治疗,在常规抗心力衰竭治疗(强心、利尿、扩血管、心肌细胞营养剂),口服胺碘酮0.2 g,每日3次,连服7 d后改为0.2 g,每日两次,再用7 d,减为0.2 g,每日1次,维持剂量0.2 g,每天1次,维持6周。结果胺碘酮治疗心力衰竭并室性心律失常的疗效,心功能改善,心率及心电图指标得到改善。结论胺碘酮用于治疗充血性心力衰竭的室性心律失常,效果良好,短期使用毒副反应小,安全系数大,值得临床推广使用。
Objective To study the efficacy of amiodarone in treating 90 cases of congestive heart failure with ventricular arrhythmia. Methods All patients were not treated with antiarrhythmic drugs in the last 3 weeks. After treatment with conventional anti-heart failure (cardiac, diuretic, vasodilator and cardiomyocyte nutrition), 0.2 g of amiodarone was orally administered 3 times a day After serving 7d changed to 0.2 g, twice daily, then 7 d, reduced to 0.2 g, 1 day, maintaining a dose of 0.2 g, 1 day, for 6 weeks. Results Amiodarone treatment of heart failure and ventricular arrhythmia efficacy, cardiac function improved, heart rate and ECG indicators improved. Conclusions Amiodarone is effective in treating ventricular arrhythmia in patients with congestive heart failure. The short-term side effects are less toxic and the safety factor is larger, which is worthy of clinical application.